...
首页> 外文期刊>American Journal of Case Reports >Flow cytometry for diagnosis of a rare case of chronic lymphocytic leukaemia presenting in the central nervous system and effective treatment with liposomal cytarabine
【24h】

Flow cytometry for diagnosis of a rare case of chronic lymphocytic leukaemia presenting in the central nervous system and effective treatment with liposomal cytarabine

机译:流式细胞术可诊断中枢神经系统中罕见的慢性淋巴细胞性白血病并用脂质体阿糖胞苷有效治疗

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Chronic lymphocytic leukaemia presenting as an abnormality of the central nervous system is extremely rare, with very few cases in the literature, and the diagnosis is complicated. This is the first published case report on the efficacy of maintenance treatment with liposomal cytarabine of central nervous system involvement in chronic lymphocytic leukaemia in our department.Case Report: We report the case of a 54-year-old male Caucasian Polish patient with a long (>10 years) history of chronic lymphocytic leukaemia who manifested cerebral symptoms. Magnetic resonance imaging revealed neoplastic meningitis. A flow cytometry analysis of cerebrospinal fluid confirmed the presence of clonal B lymphocytes. At first, the treatment was based on drugs such as methotrexate, cytarabine and dexamethasone, which were intrathecally administered. When complete remission had been reached, depot liposomal cytarabine (DepoCyte) administration was started. The patient received liposomal cytarabine every 3–4 weeks 7 times in total as a maintenance treatment and this therapy was well tolerated. Central nervous system treatment was performed parallel with systematic therapy (fludarabine and cyclophosphamide). Complete remission with minimal residual disease negativity in bone marrow was obtained. Complete remission in the central nervous system was confirmed by magnetic resonance imaging and cerebrospinal fluid is still kept 16 months after central nervous system remission.Conclusions: This is the first therapeutic use of liposomal cytarabine as maintenance treatment in our clinic. Its use in conjunction with systematic chemotherapy appears to be effective and safe since complete remission has been achieved for 16 months since maintenance therapy began.
机译:背景:以中枢神经系统异常表现的慢性淋巴细胞性白血病极为罕见,文献报道的病例很少,诊断很复杂。这是本部门首次发表的中枢神经系统脂质体阿糖胞苷维持治疗参与慢性淋巴细胞性白血病疗效的病例报告。病例报告:我们报告了一名54岁的男性白种人波兰人长期(> 10年)有脑症状的慢性淋巴细胞性白血病病史。磁共振成像显示肿瘤性脑膜炎。脑脊液的流式细胞仪分析证实了克隆B淋巴细胞的存在。起初,治疗是基于鞘内注射甲氨蝶呤,阿糖胞苷和地塞米松等药物。当达到完全缓解时,开始施用脂质体阿糖胞苷(DepoCyte)。该患者每3-4周共接受7次脂质体阿糖胞苷作为维持治疗,并且该疗法耐受性良好。中枢神经系统治疗与系统治疗(氟达拉滨和环磷酰胺)同时进行。获得了完全缓解,并使骨髓中的残留疾病阴性率降至最低。磁共振成像证实中枢神经系统完全缓解,中枢神经系统缓解后16个月仍保留脑脊液。结论:这是脂质体阿糖胞苷在我们诊所的首次治疗用途。自维持治疗开始以来,已达到16个月的完全缓解,将其与系统化学疗法结合使用似乎是有效和安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号